Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

[1]  William R. Fair,et al.  DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .

[2]  A. Belldegrun,et al.  New Perspectives in Prostate Cancer , 1998 .

[3]  A. Pollack,et al.  External beam radiotherapy dose response of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[4]  Chantal Ginestet,et al.  Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment , 1997 .

[5]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[6]  M. Zelefsky,et al.  Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. , 1997, Urology.

[7]  A. Fortin,et al.  Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[8]  G J Kutcher,et al.  The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. , 1997, International journal of radiation oncology, biology, physics.

[9]  M. Roach,et al.  Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. , 1996, The Journal of urology.

[10]  T E Schultheiss,et al.  Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. , 1996, International journal of radiation oncology, biology, physics.

[11]  R Mohan,et al.  Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. , 1996, International journal of radiation oncology, biology, physics.

[12]  T E Schultheiss,et al.  Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. , 1996, International journal of radiation oncology, biology, physics.

[13]  G Starkschall,et al.  Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. , 1996, International journal of radiation oncology, biology, physics.

[14]  C. Orton,et al.  Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. , 1996, International journal of radiation oncology, biology, physics.

[15]  78 The potential of optimized intensity modulation to escalate prostate dose to 86.4 GY , 1996 .

[16]  D. Spelbring,et al.  The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[17]  H. Sandler,et al.  Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. , 1995, International journal of radiation oncology, biology, physics.

[18]  C. Ling,et al.  The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. , 1995, The cancer journal from Scientific American.

[19]  T. Schultheiss,et al.  Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. , 1995, International journal of radiation oncology, biology, physics.

[20]  D. Kuban,et al.  Potential benefit of improved local tumor control in patients with prostate carcinoma , 1995, Cancer.

[21]  L. Verhey,et al.  Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.

[22]  L. Verhey,et al.  The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[23]  G. Perry,et al.  Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. , 1995, Urology.

[24]  J. Forman,et al.  Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation. , 1995, Cancer investigation.

[25]  M. Zelefsky,et al.  Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. , 1994, International journal of radiation oncology, biology, physics.

[26]  R Mohan,et al.  The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. , 1994, Seminars in oncology.

[27]  G. Chen,et al.  Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques. , 1993, International journal of radiation oncology, biology, physics.

[28]  G E Hanks,et al.  Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. , 1992, International journal of radiation oncology, biology, physics.

[29]  P. Rubin,et al.  Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. , 1991, International journal of radiation oncology, biology, physics.

[30]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[31]  W. van Putten,et al.  Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. , 1990, International journal of radiation oncology, biology, physics.

[32]  G E Hanks,et al.  The effect of dose on local control of prostate cancer. , 1988, International journal of radiation oncology, biology, physics.

[33]  P. Scardino,et al.  The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. , 1986, The Journal of urology.

[34]  R. Rhamy,et al.  Extended biopsy followup after full course radiation for resectable prostatic carcinoma. , 1975, The Journal of urology.